158 related articles for article (PubMed ID: 30904896)
21. Long-term administration of pegylated liposomal doxorubicin at almost twice the recommended lifetime dose in 10 years without cardiotoxicity in a Japanese patient with HIV-associated Kaposi sarcoma.
Yokota K; Yotsumoto M; Muramatsu T; Saito M; Kamikubo Y; Ichiki A; Chikasawa Y; Bingo M; Hagiwara T; Amano K; Fukutake K
J Infect Chemother; 2020 Feb; 26(2):289-291. PubMed ID: 31537471
[TBL] [Abstract][Full Text] [Related]
22. Total resolution of ocular Kaposi sarcoma with different treatment approaches - a case series and review of literature.
Yeak J; Iqbal T; Zahari M; Ismail F
Int J STD AIDS; 2019 Jul; 30(8):802-809. PubMed ID: 31046617
[No Abstract] [Full Text] [Related]
23. Bloody pleural effusion and ascites associated with Kaposi sarcoma in a kidney transplant patient.
Moghaddasi S; Nouri-Majelan N; Masoumi Dehshiri R
Iran J Kidney Dis; 2014 Sep; 8(5):424-6. PubMed ID: 25194411
[TBL] [Abstract][Full Text] [Related]
24. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Hosseinipour MC; Kang M; Krown SE; Bukuru A; Umbleja T; Martin JN; Orem J; Godfrey C; Hoagland B; Mwelase N; Langat D; Nyirenda M; MacRae J; Borok M; Samaneka W; Moses A; Mngqbisa R; Busakhala N; Martínez-Maza O; Ambinder R; Dittmer DP; Nokta M; Campbell TB;
Clin Infect Dis; 2018 Jul; 67(2):251-260. PubMed ID: 29365083
[TBL] [Abstract][Full Text] [Related]
25. Skin nodules in a young patient with HIV/AIDS.
Hashmi H; Alexander JS
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537597
[TBL] [Abstract][Full Text] [Related]
26. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
[TBL] [Abstract][Full Text] [Related]
28. [Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].
Klingenberg RE; Esser S; Brockmeyer NH; Michalik C; Skaletz-Rorowski A; Potthoff A;
Hautarzt; 2018 Feb; 69(2):143-148. PubMed ID: 29101417
[TBL] [Abstract][Full Text] [Related]
29. Primary Kaposi sarcoma of the subcutaneous tissue.
Pantanowitz L; Mullen J; Dezube BJ
World J Surg Oncol; 2008 Sep; 6():94. PubMed ID: 18764944
[TBL] [Abstract][Full Text] [Related]
30. Editorial commentary: treatment of Kaposi sarcoma in the highly active antiretroviral therapy era.
Dupin N; Del Giudice P
Clin Infect Dis; 2008 Aug; 47(3):418-20. PubMed ID: 18582204
[No Abstract] [Full Text] [Related]
31. Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'.
Chabria S; Barakat L; Ogbuagu O
Int J STD AIDS; 2016 Oct; 27(11):1026-9. PubMed ID: 26769754
[TBL] [Abstract][Full Text] [Related]
32. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
[TBL] [Abstract][Full Text] [Related]
33. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Kaposi's sarcoma associated with immune reconstitution inflammatory syndrome.
Silva L; Azurara L; Monteiro AF; Miroux-Catarino A; Amaro C; Viana I
Pediatr Dermatol; 2020 Jan; 37(1):239-240. PubMed ID: 31755571
[TBL] [Abstract][Full Text] [Related]
35. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Kaposi's Sarcoma and Its Complications in the HAART Era: A Contemporary Case-Based Review.
Epelbaum O; Go R; Patel G; Braman S
Lung; 2016 Feb; 194(1):163-9. PubMed ID: 26826066
[TBL] [Abstract][Full Text] [Related]
37. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
38. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
Connick E; Kane MA; White IE; Ryder J; Campbell TB
Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
[TBL] [Abstract][Full Text] [Related]
39. Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome.
Godoy MC; Rouse H; Brown JA; Phillips P; Forrest DM; Müller NL
AJR Am J Roentgenol; 2007 Oct; 189(4):956-65. PubMed ID: 17885071
[TBL] [Abstract][Full Text] [Related]
40. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
Volkow P; Chavez Galan L; Ramon-Luing L; Cruz-Velazquez J; Cornejo-Juarez P; Sada-Ovalle I; Perez-Padilla R; Islas-Muñoz B;
PLoS One; 2023; 18(5):e0280209. PubMed ID: 37195970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]